IKS Health Delivers Strong Q1 FY27 Results with 21% Year-Over-Year Revenue Growth and 28% Year-Over-Year PAT Increase

Q1 Revenue growth 21% YoY in INR, 12% YoY in USD

Q1 EBITDA 24% YoY

Q1 PAT up 28% YoY Inventurus Knowledge Solutions Limited (NSE: IKS), a global healthcare technology company, today announced its financial results for the quarter ended June 30, 2026, reporting strong revenue and profit growth in Q1 FY 2027. IKS Health partners with health systems, physician groups, specialty practices, and rural and community hospitals to improve operational efficiency, financial sustainability, and care delivery through technology-enabled solutions and deep healthcare expertise. The IKS Health platform integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better outcomes, and financially sustainable growth across the care journey.“This quarter’s results showcase the resilience of our business model, powered by strong client trust, operational efficiency, and a scalable care enablement platform. This continued momentum builds on a decade of profitable growth, marked by an impressive 46% PAT CAGR,” said Sachin K. Gupta, Founder & Global CEO, IKS Health. “The acquisition of TruBridge marks an important milestone in our growth journey, expanding our capabilities and strengthening our ability to serve a broader range of healthcare organizations, including rural and community health systems. By bringing together complementary expertise, technology, and healthcare capabilities, we are well-positioned to create greater value for our clients and drive sustainable growth over the long term.”Nithya Balasubramanian, Group CFO, IKS Health said, “We closed Q1 FY27 with robust financial results, delivering 21% YoY revenue growth and a 28% YoY growth in PAT. These outcomes are a direct result of our unwavering focus on cost discipline, platform scalability, and capital efficiency. As we look to the rest of the fiscal year, our priority remains clear: protecting our margins while investing prudently in the strategic capabilities that secure long-term value.”Key Financial Highlights: Q1FY27 ended on June 30, 2026